As genomic medicine advances, family medicine is entering a new era—one that combines the power of genetic insights with the personal relationships and continuity of care that have always defined the specialty. Discover how integrating genomics into primary care can transform disease prevention, improve patient outcomes, and empower physicians to deliver more personalized, proactive care while staying true to the heart of family medicine: understanding the whole person and their family history.

Mary Hames is a seasoned Medical Affairs executive with a proven track record of leading high-performing teams and delivering strategic impact across rare disease, diagnostics, and oncology. With a foundation in biochemical genetics and over a decade of industry experience, she has played pivotal roles in clinical operations, launch preparedness, and cross-functional leadership. Known for her ability to navigate complex medical landscapes, Mary has successfully built and led medical teams, advanced companion diagnostics, and driven field strategy across multiple therapeutic areas. Her leadership is marked by scientific rigor, operational excellence, and a deep commitment to improving outcomes for patients with rare and life-threatening conditions.